Merck & Co Inc's quarterly results beat estimates, helped by strong sales of its Januvia diabetes drug and Gardasil vaccine against cervical cancer, but the company forecast 2013 profit at the low end of expectations.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment